Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

EMA grants PRIME designation to AMT-060 in hemophilia B

April 26, 2017

Akari presents new data on Coversin

April 25, 2017

Interim results from phase III HAVEN 2 pediatric trial of emicizumab in hemophilia A

April 18, 2017

Rigel submits NDA for fostamatinib for chronic ITP

April 18, 2017

BioCryst Pharmaceuticals announces plans to test oral liquid formulation of BCX-7353

April 13, 2017

Achillion initiates phase II study of ACH-4471 in paroxysmal nocturnal hemoglobinuria

April 7, 2017

ProMetic Life Sciences completes plasminogen BLA filing

April 6, 2017

CSL Behring's Kcentra approved in Japan

April 4, 2017

FDA grants fast track designation to Coversin for PNH

March 31, 2017

French approval for Eprex within E.U. mutual recognition procedure

March 27, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...